Literature DB >> 9111436

Predictors of recurrent febrile seizures. A prospective cohort study.

A T Berg1, S Shinnar, A S Darefsky, T R Holford, E D Shapiro, M E Salomon, E F Crain, A W Hauser.   

Abstract

OBJECTIVES: To define the risk and identify predictors of single and multiple recurrent febrile seizures.
METHODS: Children (n = 428) with first febrile seizures were prospectively identified and followed for 2 or more years. Parents were interviewed soon after their children's first febrile seizure and were called every 3 months to ascertain recurrent febrile seizures. Medical records of first and recurrent seizures were reviewed for additional information.
RESULTS: A total of 136 children (31.8%) experienced recurrent seizures: 73 (17.1%) had only 1 recurrence, 38 (8.9%) had 2 recurrences, and 25 (5.8%) had 3 or more recurrences. Young age at onset, a history of febrile seizures in a first-degree relative, low degree of fever while in the emergency department, and a brief duration between the onset of fever and the initial seizure were strong independent predictors of recurrent febrile seizures. With these 4 factors combined, it is possible to define groups of children having very high and very low probabilities of having any recurrences (> 70% vs < 20%), having 2 or more recurrences (> 60% vs < 10%), and having 3 or more recurrence (12% vs about 0%). In children who had at least 1 recurrence, age at the time of the first recurrence and a family history of epilepsy were predictors of subsequent recurrences.
CONCLUSIONS: In children who have had a first febrile seizure, recurrences are common. The risk for 1 or more recurrences can be meaningfully predicted at the time of the initial febrile seizure with a combination of the 4 factors identified in this study.

Entities:  

Mesh:

Year:  1997        PMID: 9111436     DOI: 10.1001/archpedi.1997.02170410045006

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  26 in total

1.  Identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+) on chromosome 2q24-q33.

Authors:  B Moulard; M Guipponi; D Chaigne; D Mouthon; C Buresi; A Malafosse
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

Review 2.  Febrile seizures.

Authors:  Lynette G Sadleir; Ingrid E Scheffer
Journal:  BMJ       Date:  2007-02-10

3.  Febrile seizures: a cloudy issue.

Authors:  Efterpi Pavlidou; Christos Panteliadis
Journal:  Eur J Pediatr       Date:  2009-07-04       Impact factor: 3.183

Review 4.  Neuropeptide Y: potential role in recurrent developmental seizures.

Authors:  Celine Dubé
Journal:  Peptides       Date:  2006-12-29       Impact factor: 3.750

Review 5.  Epileptogenesis after prolonged febrile seizures: mechanisms, biomarkers and therapeutic opportunities.

Authors:  Shawn McClelland; Céline M Dubé; Jaqueline Yang; Tallie Z Baram
Journal:  Neurosci Lett       Date:  2011-02-26       Impact factor: 3.046

Review 6.  Febrile seizures: mechanisms and relationship to epilepsy.

Authors:  Céline M Dubé; Amy L Brewster; Tallie Z Baram
Journal:  Brain Dev       Date:  2009-02-15       Impact factor: 1.961

7.  Relationship between five common viruses and febrile seizure in children.

Authors:  Brian Chung; Virginia Wong
Journal:  Arch Dis Child       Date:  2007-02-06       Impact factor: 3.791

Review 8.  Febrile seizures: an update.

Authors:  C Waruiru; R Appleton
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

9.  Risk factors for subsequent febrile seizures in the FEBSTAT study.

Authors:  Dale C Hesdorffer; Shlomo Shinnar; Daniel N Lax; John M Pellock; Douglas R Nordli; Syndi Seinfeld; William Gallentine; L Matthew Frank; Darrell V Lewis; Ruth C Shinnar; Jacqueline A Bello; Stephen Chan; Leon G Epstein; Solomon L Moshé; Binyi Liu; Shumei Sun
Journal:  Epilepsia       Date:  2016-06-06       Impact factor: 5.864

Review 10.  Febrile seizures: recent developments and unanswered questions.

Authors:  Efterpi Pavlidou; Christian Hagel; Christos Panteliadis
Journal:  Childs Nerv Syst       Date:  2013-07-12       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.